e-learning
resources
Virtual 2021
05.09.2021
French programme 2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pneumopathies infiltrantes diffuses sous immunothérapie / Interstitial lung diseases and immunotherapy
J. Cadranel (Paris Cedex 20, France)
Source:
Virtual Congress 2021 – French programme 2021
Session:
French programme 2021
Session type:
Language session
Number:
64
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Cadranel (Paris Cedex 20, France). Pneumopathies infiltrantes diffuses sous immunothérapie / Interstitial lung diseases and immunotherapy. Virtual Congress 2021 – French programme 2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Combination therapy in the era of immunotherapy
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
New pathways, new targets
Related content which might interest you:
Plethysmographic profil of patients with infiltrative lung diseases
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013
Interstitial lung disease: are we missing formes frustes of connective tissue disease?
Source: Eur Respir J 2006; 28: 893-896
Year: 2006
Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Interstitial lung diseases
Source: HERMES Summer School 2014 - Educational material
Year: 2014
Interstitial lung diseases
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018
Interstitial lung diseases
Source: Eur Respir Monogr 2014; 65: 79-87
Year: 2014
Interstitial lung diseases
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019
Interstitial lung diseases
Source: Eur Respir Monogr 2015; 70: 99-115
Year: 2015
Interstitial lung diseases
Source: Annual Congress 2012 - MS4 Interpreting high-resolution computed tomography scans: top tips
Year: 2012
Interstitial lung diseases
Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I
Year: 2013
Interstitial lung diseases
Source: ERS Course 2015
Year: 2015
LATE-BREAKING ABSTRACT: Efficacy of inhaled N-acetylcystein in patients with interstitial pneumonia
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last !
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020
Microbiote et cancer bronchique: l'exemple de l'immunothérapie / Microbiota and lung cancer: an example of immunotherapy
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Interstitial lung diseases today
Source: Eur Respir Mon; 2009: 46: 1–3
Year: 2009
Interstitial lung diseases in children
Source: Annual Congress 2011 - Paediatric Year in Review
Year: 2011
Interstitial lung diseases 2017
Source: International Congress 2017 – Clinical year in review
Year: 2017
Prise en charge de l’aspergillose pulmonaire chronique Chronic pulmonary aspergillosis care
Source: International Congress 2017 – French Programme 2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept